Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.430
+0.010 (0.70%)
At close: Oct 29, 2026, 4:00 PM EDT
1.400
-0.030 (-2.10%)
Pre-market: Oct 30, 2026, 4:00 AM EDT
ZYBT Market Cap
ZYBT has a market cap or net worth of $67.77 million as of October 29, 2026. It is the 27,840th most valuable company in the world and the 4,417th biggest in the United States. Its market cap has decreased by 34.40% in one year.
Market Cap
67.77M
Enterprise Value
71.09M
1-Year Change
-34.40%
Global Rank
Country Rank
#4,417 United States
Category
ChartMarket Cap Chart
Since the IPO on January 7, 2025, ZYBT's market cap has decreased from $188.67M to $67.77M, a decrease of -64.08%. That is a compound annual growth rate of -43.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 67.77M | 24.35% |
| Dec 31, 2025 | 54.50M | -71.11% |
| Jan 7, 2025 | 188.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Journey Medical | 139.99M |
| Cardiol Therapeutics | 134.74M |
| Organigram Global | 132.52M |
| BGM Group | 119.85M |
| Organogenesis Holdings | 116.12M |
| Cumberland Pharmaceuticals | 74.17M |
| Citius Oncology | 64.62M |
| Talphera | 56.58M |